Global Fucoidan Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Fucoidan Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Fucoidan is a specific source of sliminess only found in brown algae such as kombu, wakame (mekabu) and mozuku, and a type of water-soluble dietary fiber. Chemically, fucoidan is a high-molecular polysaccharide whose main constituent is sulfated fucose. In addition to fucose, the saccharide chain that constitutes fucoidan also includes galactose, mannose, xylose and uronic acid. The name “fucoidan” does not represent substances of a given structure, but it is a general term that refers to high-molecular polysaccharides whose main constituent is fucose.

Market Overview:

The latest research study on the global Fucoidan market finds that the global Fucoidan market reached a value of USD 32.92 million in 2022. It’s expected that the market will achieve USD 52.16 million by 2028, exhibiting a CAGR of 7.97% during the forecast period.

SWOT Analysis

Strength

Fucoidan is used as an antioxidant. It is also used as anticoagulant, anti-inflammatory, antiviral, anti-angiogenic, antitumor; and antithrombotic agent. Growth in the pharmaceutical industry is boosting the demand for fucoidan across the globe.
Fucoidan has been widely used in health foods, dietary supplements, beverages, candies, and also used in products such as creams, lotions and shampoos.
With the rapid development of the economy and the intensified aging of society, contemporary people will pay more and more attention to health care.

Weakness

Heavy metal contamination of seaweed due to oceanic pollution degrades the purity of fucoidan.

Opportunities

Recent anti-cancer drug R&D activities and the synergistic effect of fucoidan with chemotherapeutics to eliminate tumor cells are expected to promote the global fucoidan market in the near future.
Various latest studies have found that fucoidan has an inhibitory effect on the growth of Helicobacter pylori and stomach infections, and can inhibit the secretion and release of key pro inflammatory factors related to acute and chronic intestinal diseases. Fucoidan has the effect of reducing urea nitrogen, improving renal function and delaying the progression of the disease for chronic renal failure.

Region Overview:

North America is projected to account for a considerable share of the Fucoidan market and is expected to become the largest region by 2027.

Company Overview:

Haerim Fucoidan
Haerim Fucoidan was born from investments from Jeollanam-do, Wando-gun, and the Ministry of Maritime Affairs and Fisheries. It is a 100% pure Korean fucoidan production company. Harim Fucoidan secures world-class capabilities in extracting core functional substances contained in small amounts of seaweed. High-quality products can be produced at the most competitive prices through world-class production facilities built with government support.

DuPont

DuPont is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Its employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety.

Segmentation Overview:

Among different product types, Purity ≥ 95% segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Dietary Supplement segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Fucoidan market covered in Chapter 3:

Qingdao Rongde
Marinova
Hi-Q Marine Biotech
BMSG
Haerim Fucoidan
Yaizu Suisankagaku
Sea Herb
DuPont
Kamerycah
Kanehide

In Chapter 4 and Chapter 14.2, on the basis of types, the Fucoidan market from 2018 to 2029 is primarily split into:

Purity 85%-90%
Purity 90%-95%
Purity ≥ 95%
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Fucoidan market from 2018 to 2029 covers:

Pharmaceutical
Dietary Supplement
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)